Luspatercept in Preventing Poor Erythroid Engraftment for Hematological Malignancies With Moderate to Severe Myelofibrosis

Clinical trial NCT07539779 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07539779
Sponsor: Nanfang Hospital, Southern Medical University
Status: NOT_YET_RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Luspatercept Poor Erythroid Engraftment Hematological Malignancies Myelofibrosis (MF)

Start date: 2026-05-01
Primary completion: 2030-01-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.